Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05191433
Other study ID # COVID DIAPHRAGM
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date January 20, 2022

Study information

Verified date January 2022
Source Azienda Sanitaria-Universitaria Integrata di Udine
Contact Luigi Vetrugno, MD
Phone + 39 0432559509
Email luigi.vetrugno@asufc.sanita.fvg.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The diaphragm is the fundamental muscle of the respiratory system. The diaphragmatic dysfunction is present in 60% of critical patients at hospital admission and up to 80% after prolonged mechanical ventilation and difficult weaning. Risk factors associated with diaphragm dysfunction and atrophy are sepsis, trauma, sedatives, steroids, and muscle relaxants. The main pathology characteristics of diaphragm biopsies of mechanically ventilated patients are atrophy and a reduction in contractility, determining an impact on the clinical outcome. Shi et al. found a higher section area of the diaphragm muscle fiber in biopsies of post mortem COVID-19 patients versus negative patients, independently from days of mechanical ventilation. The hypothesis of our study is to identify different clusters of pathological presentation in post-mortem COVID-19 mechanically ventilated patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 41
Est. completion date January 20, 2022
Est. primary completion date March 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - patients deceased in the intensive care unit positive to SARS-CoV-2 and mechanically ventilated - post-mortem examination of the diaphragm Exclusion Criteria: - patients with a terminal disease and a prognosis of less than 48 hours at admission.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Italy Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD Udine
Italy Azienda ospedaliero universitaria Friuli Centrale, Clinica di Anestesia e Rianimazione Udine

Sponsors (1)

Lead Sponsor Collaborator
Azienda Sanitaria-Universitaria Integrata di Udine

Country where clinical trial is conducted

Italy, 

References & Publications (6)

Dres M, Goligher EC, Heunks LMA, Brochard LJ. Critical illness-associated diaphragm weakness. Intensive Care Med. 2017 Oct;43(10):1441-1452. doi: 10.1007/s00134-017-4928-4. Epub 2017 Sep 15. Review. — View Citation

Goligher EC, Dres M, Fan E, Rubenfeld GD, Scales DC, Herridge MS, Vorona S, Sklar MC, Rittayamai N, Lanys A, Murray A, Brace D, Urrea C, Reid WD, Tomlinson G, Slutsky AS, Kavanagh BP, Brochard LJ, Ferguson ND. Mechanical Ventilation-induced Diaphragm Atrophy Strongly Impacts Clinical Outcomes. Am J Respir Crit Care Med. 2018 Jan 15;197(2):204-213. doi: 10.1164/rccm.201703-0536OC. — View Citation

Hooijman PE, Beishuizen A, Witt CC, de Waard MC, Girbes AR, Spoelstra-de Man AM, Niessen HW, Manders E, van Hees HW, van den Brom CE, Silderhuis V, Lawlor MW, Labeit S, Stienen GJ, Hartemink KJ, Paul MA, Heunks LM, Ottenheijm CA. Diaphragm muscle fiber weakness and ubiquitin-proteasome activation in critically ill patients. Am J Respir Crit Care Med. 2015 May 15;191(10):1126-38. doi: 10.1164/rccm.201412-2214OC. — View Citation

McCool FD, Manzoor K, Minami T. Disorders of the Diaphragm. Clin Chest Med. 2018 Jun;39(2):345-360. doi: 10.1016/j.ccm.2018.01.012. Review. — View Citation

Shi Z, Bogaards SJP, Conijn S, Onderwater Y, Espinosa P, Bink DI, van den Berg M, van de Locht M, Bugiani M, van der Hoeven H, Boon RA, Heunks L, Ottenheijm CAC. COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients. BMJ Open Respir Res. 2021 Sep;8(1). pii: e001052. doi: 10.1136/bmjresp-2021-001052. — View Citation

Supinski GS, Morris PE, Dhar S, Callahan LA. Diaphragm Dysfunction in Critical Illness. Chest. 2018 Apr;153(4):1040-1051. doi: 10.1016/j.chest.2017.08.1157. Epub 2017 Sep 5. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical characteristics Evaluate if there are specific clusters in the study population and find different clinical characteristics. One week post mortem
Primary Blood test characteristics Evaluate if there are specific clusters in the study population and find different blood test characteristics. One week post mortem
Primary Pathology characteristics Evaluate if there are specific clusters in the study population and find different pathology characteristics. One week post mortem
Secondary Mechanical ventilation Verify if there are correlations between the clusters characteristics and the other variables in the study population mechanical ventilation. One week post mortem
Secondary Therapy Verify if there are correlations between the clusters characteristics and therapy in the study population. One week post mortem
Secondary Arterial blood gas analysis Verify if there are correlations between the clusters characteristics and arterial blood gas in the study population. One week post mortem